BioSpark discussion: The future T-cell Therapies for Cancer
汇聚群英智慧，闪亮你我星光
Together, Spark Biomedicine!
Event Introduction
Join us to learn The future T-cell Therapies for Cancer from the leading academics, biotech executives, and healthcare entrepreneurs, from the US and China. Be there or be square!
Topic：The future T-cell Therapies for Cancer, from scientific, investment, and BD perspectives.
Time：May 8th, 2021 9pm EST （北京时间5月9日上午9点）
Clubhouse link: https://www.joinclubhouse.com/event/myYdjb4D
Zoom link：https://us06web.zoom.us/j/84116335039?pwd=S2hGVWVENDNMdE5WbzZBS0pQSlNwQT09 (或点击文末“阅读原文”)
Speakers：
Cassian Yee, MD Anderson Cancer Center (https://www.linkedin.com/in/cassian-yee-6140764/)
Jimmy Wang, New York University (https://www.linkedin.com/in/jun-jimmy-wang-69a16a58/)
Wenjun Sun, JW Therapeutics (https://www.linkedin.com/in/wenjun-sun-1b2a3313b/)
Moderators：
Jun Tang, Henlius Biotech (https://www.linkedin.com/in/juntangnyc/)
Zhaoying Xu, Health Advances (https://www.linkedin.com/in/zhaoyingxu/)
Qinghong Yan, FUSION BioVenture (http://linkedin.com/in/qinghong-yan)
BioSpark Group成立于2019年8月，是在美国麻省注册的非盈利机构。BioSpark致力于推动生命科学领域的高级人才交流，建立富有合作和互助精神的社群生态环境，实现学术和企业的跨界交流及思想碰撞，从而帮助华人科学家在世界生物医药领域提升领导力、开拓企业家精神及促进科学发现的商业转化。
BioSpark Group is a non-profit corporation registered in Massachusetts of the United States. The purpose of BioSpark Group is to establish a biotechnology ecosystem with a collaborative and supportive scholar network, promote leadership and entrepreneurship, and facilitate scientific translation.
欢迎在生物医药领域各行各业的、有想法、想做事、有合作精神的伙伴们加入我们，让我们一起发展壮大。联系方式：biospark.boston@gmail.com （请附自我介绍和简历）
战略合作
波士顿和硅谷是美国乃至全球的生物医药创新中心，BioSpark立足波士顿，同时在硅谷和波士顿与LEAP Initiative 和Dahshu达成战略合作，共同建立华人在生物医药领域的生态系统和互助网络。更多精彩，请关注BioSpark公众号